Nureca Q4 FY26 Results: Net Profit Rs 32.31 Crore, Revenue and Key Financial Highlights

Nureca Q4 FY26 results were declared on May 29, 2026. The company reported net profit of Rs 32.31 crore for the quarter ended March 31, 2026, reflecting its operational performance in the January to March 2026 period. Revenue details for the quarter are available in the BSE/NSE audited filing declared May 29, 2026. Nureca operates in the healthcare devices sector and is listed on Indian stock exchanges. India’s strong macroeconomic backdrop, including GDP growth above 6.5% and the RBI’s supportive monetary stance, shaped the operating environment in Q4 FY26.

Click Here – Get Free Investment Predictions

Nureca Q4 FY26 Financial Highlights

Data sourced from company filings and public disclosures. Always verify from BSE/NSE audited filings before investment decisions.

Nureca Q4 FY26 Performance Analysis

The Nureca Q4 FY26 results reflect performance in the January to March 2026 quarter, the seasonally important fourth quarter of the financial year. Revenue details are available in the BSE/NSE audited filing. Net profit of Rs 32.31 crore demonstrates the company’s operational efficiency. The January to March 2026 quarter was characterised by sustained domestic demand recovery, government infrastructure spending, and the RBI’s supportive monetary policy stance.

India’s macroeconomic backdrop in Q4 FY26 included GDP growth above 6.5%, central government capex of Rs 11.21 lakh crore budgeted for FY27, and stable inflationary conditions. These factors provided a constructive operating environment for listed companies across sectors during the quarter ended March 31, 2026.

Key Business Factors in Q4 FY26

Revenue and Business Operations

Revenue details are available in the BSE/NSE audited filing. The company’s operational performance in Q4 FY26 reflects the prevailing demand conditions in its sector. Management commentary from the board meeting on May 29, 2026 provides key insights into volume trends, pricing dynamics, and business strategy for FY27.

Profitability and Cost Management

Net profit of Rs 32.31 crore demonstrates the company’s operational efficiency. Cost management, raw material trends, and operating leverage are key factors influencing the bottom line. Investors should review the full audited financial statement available on BSE/NSE for a detailed breakdown of operating expenses and margins.

Sector and Macro Backdrop

India’s Q4 FY26 macro environment was shaped by continued GDP growth, budgeted government capex of Rs 11.21 lakh crore for FY27, and the RBI’s accommodative policy stance. These structural tailwinds supported business investment, consumer spending, and capital formation across India’s listed companies during the January to March 2026 quarter.

FY27 Outlook

Following the Nureca Q4 FY26 results, investors will focus on management guidance for FY27. Revenue growth targets, margin improvement initiatives, capital allocation plans, and sector-specific catalysts will be key inputs for FY27 performance assessment. India’s GDP growth trajectory, domestic demand trends, and global macro conditions will be important external factors shaping the FY27 outlook for Nureca.

Download the Univest iOS App or Univest Android App to track live price and daily stock recommendations.

Nureca Stock and Live Price

Shares of Nureca are listed on Indian stock exchanges. Following the Q4 FY26 results declaration on May 29, 2026, investors should monitor post-results price action, trading volumes, and management commentary. Always consult a SEBI-registered financial advisor before making investment decisions.

Key Risks

Revenue and Demand Risk

Any deceleration in India’s GDP growth, reduction in government capex, or weakening of private consumption could negatively impact demand for Nureca’s products and services in FY27.

Margin and Cost Volatility

Fluctuations in raw material costs, energy prices, and logistics expenses pose margin risks. Cost escalation without corresponding pricing power could compress profitability from Q4 FY26 levels.

Regulatory and Competitive Risk

Changes in regulatory frameworks, increased competitive pressure from domestic or global peers, and customer concentration risks are key watchpoints for investors in Nureca.

Conclusion

Nureca Q4 FY26 results were declared on May 29, 2026. The company reported net profit of Rs 32.31 crore for the quarter ended March 31, 2026. Revenue details are available in the BSE/NSE audited filing. Investors should monitor management guidance, sector trends, and BSE/NSE filings before making investment decisions. Consult a SEBI-registered financial advisor before investing.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions on Nureca Q4 FY26 Results

What is Nureca Q4 FY26 net profit?

Ans. Nureca Q4 FY26 net profit was Rs 32.31 crore. Results declared May 29, 2026.

What is Nureca Q4 FY26 revenue?

Ans. Nureca Q4 FY26 revenue details are available in the BSE/NSE audited filing declared May 29, 2026.

When were Nureca Q4 FY26 results declared?

Ans. Nureca Q4 FY26 results were declared on May 29, 2026 at the board meeting approving audited financial statements for the quarter and year ended March 31, 2026.

What dividend did Nureca declare for FY26?

Ans. Dividend details for Nureca FY26 are available in the BSE/NSE audited filing. Investors should check the filing for record date and payout schedule.

Is Nureca a good stock to buy after Q4 FY26 results?

Ans. Investment decisions require assessment of fundamentals, valuation, sector outlook, and personal risk tolerance. Consult a SEBI-registered financial advisor before making any investment in Nureca.

What is the FY27 outlook for Nureca?

Ans. Following Nureca Q4 FY26 results, management guidance on revenue growth, margin improvement, and capital allocation will shape the FY27 outlook. Monitor BSE/NSE filings and management commentary for updates.